The PFF Scholars program focuses on engaging early-career investigators in their emerging research in the field of pulmonary fibrosis. With the goal of advancing research that could translate into successful therapies for PF, the PFF Scholars program is designed to support and enable promising researchers to obtain independent funding and continue their cutting- edge research. Scholars will receive up to $50,000 over a two-year period.

Avraham Unterman, MD, MBA

Apr 21, 2021, 09:09 AM
Title : Avraham Unterman, MD, MBA
First Name : Avraham
Middle Name :
Last Name : Unterman, MD, MBA
Position :
University : Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Proposal Title :
Proposal Funder : Chuck and Monica McQuaid Family Foundation

Dr. Unterman is a physician-scientist focusing his career on research and clinical practice in idiopathic pulmonary fibrosis and other interstitial lung diseases. After completing his pulmonary fellowship at the Rabin Medical Center in Israel, he joined Dr. Naftali Kaminski’s laboratory as an Instructor at Yale School of Medicine, where he studied the immune system in IPF using the powerful technology of single-cell RNA sequencing (scRNA-seq). During the COVID-19 pandemic he led a large collaborative scRNA-seq study at Yale, uncovering the dyssynchrony of the innate and adaptive immune system in progressive COVID-19.  

Dr. Unterman attended medical school at the Technion- Israel Institute of Technology, and completed residency training in internal medicine at the Sheba Medical Center in Israel. He holds a Master of Business Administration (MBA) degree from the Technion and has published over 20 research articles and book chapters. Starting from December 2020, he will be joining the Tel Aviv Sourasky Medical Center in Israel, where he will head the Interstitial Lung Disease Service as well as a research laboratory. His current research focuses on single-cell immune profiling of the peripheral blood to identify the immunological mechanisms that distinguish immune-driven forms of pulmonary fibrosis from IPF, and facilitate the development of precision medicine approaches for diagnosis and treatment.

Load more comments
Comment by from